SkinMedica Would Like You to Know It Has a Very Large Laboratory Now
SkinMedica has expanded its research and development capabilities with an enlarged R&D lab focused on regenerative science and skin longevity. The company is applying emerging technologies and strategic collaborations to address unmet skin concerns. Prithwiraj Maitra, Ph.D., vice president of research and development, frames this as advancing skincare through scientific excellence.
The operative concept here is translational research infrastructure: the deliberate scaling of laboratory capacity to bridge basic science and commercial product development. For your own practice, the lesson is asset accumulation. Document your methods, systematize your protocols, and build reusable knowledge bases rather than relying on individual practitioner intuition.
SkinMedica, a skincare brand within the Allergan Aesthetics portfolio, is executing this expansion. The source names Prithwiraj Maitra, Ph.D., as vice president of R&D and spokesperson. No specific investment figures, laboratory square footage, or product pipeline timelines are disclosed.
Step 1: Create a simple digital knowledge base using a free tool such as Notion or Google Docs. Document one treatment protocol you currently perform, including products used, client preparation steps, and observed outcomes. Step 2: Use a free AI research assistant such as Perplexity or ChatGPT to query current peer-reviewed literature on one active ingredient in your protocol. Summarize three findings. Step 3: Draft one protocol refinement based on your literature review and schedule a date to implement and evaluate it. This approximates the R&D loop at consumer scale.